How evolutionary changes in body size are brought about by variance in developmental timing and/or growth rates (also known as heterochrony) is a topic of considerable interest in evolutionary biology. In particular, extreme size change leading to gigantism occurred within the dinosaurs on multiple occasions. Whether this change was brought about by accelerated growth, delayed maturity or a combination of both processes is unknown. A better understanding of relationships between non-avian dinosaur groups and the newfound capacity to reconstruct their growth curves make it possible to address these questions quantitatively. Here we study growth patterns within the Tyrannosauridae, the best known group of large carnivorous dinosaurs, and determine the developmental means by which Tyrannosaurus rex, weighing 5,000 kg and more, grew to be one of the most enormous terrestrial carnivorous animals ever. T. rex had a maximal growth rate of 2.1 kg d(-1), reached skeletal maturity in two decades and lived for up to 28 years. T. rex's great stature was primarily attained by accelerating growth rates beyond that of its closest relatives.
Did dinosaurs grow in a manner similar to extant reptiles, mammals or birds, or were they unique? Are rapid avian growth rates an innovation unique to birds, or were they inherited from dinosaurian precursors? We quantified growth rates for a group of dinosaurs spanning the phylogenetic and size diversity for the clade and used regression analysis to characterize the results. Here we show that dinosaurs exhibited sigmoidal growth curves similar to those of other vertebrates, but had unique growth rates with respect to body mass. All dinosaurs grew at accelerated rates relative to the primitive condition seen in extant reptiles. Small dinosaurs grew at moderately rapid rates, similar to those of marsupials, but large species attained rates comparable to those of eutherian mammals and precocial birds. Growth in giant sauropods was similar to that of whales of comparable size. Non-avian dinosaurs did not attain rates like those of altricial birds. Avian growth rates were attained in a stepwise fashion after birds diverged from theropod ancestors in the Jurassic period.
The implant does not significantly change the intradiscal pressures at the adjacent levels, yet it significantly unloads the intervertebral disc at the instrumented level in the neutral and extended positions. On the basis of the current findings, it does not appear that the implant causes accelerated disc degeneration at the adjacent levels.
Study Design. Facet loading parameters of lumbar cadaver spines were measured during extension before and after placement of an interspinous process implant.Objective. The study was undertaken to quantify the influence of an interspinous implant on facet loading at the implanted and adjacent levels during extension.Summary of Background Data. Facet loading is increased during extension and decreased during flexion. Previous studies have demonstrated that interspinous process decompression relieves disc pressure at the implanted level and does not alter disc pressure at the adjacent levels. Facet joints are believed to play a key role in back pain, especially in patients with collapsed discs and increased motion segment mobility resulting in increased facet loading.Methods. Seven cadaver spines (L2-L5) were loaded to 15 Nm of extension and 700 N compression with and without an interspinous process implant (X STOP) placed between the L3-L4 spinous processes. Pressure-sensitive film was placed in the facet joints of the implanted and adjacent levels. After loading, the film was digitally analyzed for peak pressure, average pressure, contact area, and force. These values were compared between the intact and implanted specimens at the adjacent and implanted levels using a paired t test (P Ͻ 0.05).Results. The implant significantly reduced the mean peak pressure, average pressure, contact area, and force at the implanted level. The mean peak pressure, average pressure, contact area, and force at the adjacent levels were not significantly different between the intact and implanted specimens with the exception of contact area at the L2-L3 level.Conclusions. Interspinous process decompression will unlikely cause adjacent level facet pain or accelerated facet joint degeneration. Furthermore, pain induced from pressure originating in the facets and/or posterior anulus of the lumbar spine may be relieved by interspinous process decompression. Clinical results from patients with a component of lower back pain suggest that this is a valid conclusion.Key words: facet joint, neurogenic intermittent claudication, lumbar, back pain, interspinous process decompression. Spine 2005;30:903-907Although the precise etiology of lower back pain (LBP) lacks a general consensus, there is general agreement that the facet joints must be considered when studying its pathology. 1-7 The lifetime incidence of LBP is estimated to be between 60% and 90% with 15% to 40% of chronic LBP caused by the lumbar facet joints. 8 -10 Although clinically difficult to diagnose, facet specific back pain is exacerbated by hyperextension and lessened in a recumbent position or flexion. 1,6,8 During extension, loading of the facet joints is increased, resulting in compression of the nerve root and central canals and deformation of the joint capsule. 6,9 It is believed that the deformation of the joint capsule is the source of pain as it stimulates nociceptors of the capsule. 8,11 The capsule surrounding the facet joint has been shown to be well innervated by aff...
This hydroxyapatite cement compound augments anterior column stability in a burst fracture model. This technique may improve outcomes in burst fracture patients without the need for a secondary anterior approach.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.